Data / Form D filings / Kun Run Biotechnology, Inc.
Kun Run Biotechnology, Inc.: Form D filing
Kun Run Biotechnology, Inc., a pharmaceuticals company in Haikou City, Hainan Province, China, filed a Form D with the SEC in 2010. The latest, on May 13, 2010, reports $8 million sold of a $8 million offering to 1 investor.
Find out what Kun Run Biotechnology, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Free Trade Zone, 168 Nanhai Avenue, Haikou City, Hainan Province, China, 57021
- Phone
- 86-898-6680-2207
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2006
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1393526
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2010 | New notice | $8,000,000 | $8,000,000 | $0 | 1 | Apr 30, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Xueyun Cui | Director | |
| Yan Lin | Executive Officer | |
| Xiaoqun Ye | Executive Officer | |
| Nancy Chang | Director |
Every Form D from the week of May 10, 2010 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Kun Run Biotechnology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.